Walter Mier

19.6k total citations · 13 hit papers
243 papers, 15.1k citations indexed

About

Walter Mier is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Walter Mier has authored 243 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Radiology, Nuclear Medicine and Imaging, 89 papers in Molecular Biology and 70 papers in Oncology. Recurrent topics in Walter Mier's work include Radiopharmaceutical Chemistry and Applications (83 papers), Monoclonal and Polyclonal Antibodies Research (43 papers) and Peptidase Inhibition and Analysis (38 papers). Walter Mier is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (83 papers), Monoclonal and Polyclonal Antibodies Research (43 papers) and Peptidase Inhibition and Analysis (38 papers). Walter Mier collaborates with scholars based in Germany, United States and Switzerland. Walter Mier's co-authors include Uwe Haberkorn, Clemens Kratochwil, Frederik L. Giesel, Jürgen Debus, Annette Altmann, Michael Eisenhut, Klaus Kopka, Matthias Eder, Thomas Lindner and Martin Schäfer and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Walter Mier

239 papers receiving 14.9k citations

Hit Papers

68Ga-FAPI PET/CT: Tracer Up... 2005 2026 2012 2019 2019 2012 2018 2005 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
    2019 964 citations Clemens Kratochwil, Paul Flechsig et al. Journal of Nuclear Medicine profile →
  2. 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
    2012 688 citations Matthias Eder, Martin Schäfer et al. profile →
  3. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein
    2018 644 citations Annette Altmann, Frederik L. Giesel et al. Journal of Nuclear Medicine profile →
  4. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis
    2005 563 citations Armin Schneider, Carola Krüger et al. Journal of Clinical Investigation profile →
  5. A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
    2018 534 citations Walter Mier, Jürgen Debus et al. Journal of Nuclear Medicine profile →
  6. 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
    2018 488 citations Frederik L. Giesel, Clemens Kratochwil et al. Journal of Nuclear Medicine profile →
  7. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
    2015 464 citations Martin Schäfer, Ulrike Bauder‐Wüst et al. Journal of Nuclear Medicine profile →
  8. PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
    2016 463 citations Clemens Kratochwil, Frederik L. Giesel et al. Journal of Nuclear Medicine profile →
  9. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
    2016 441 citations Frederik L. Giesel, Martin Schäfer et al. profile →
  10. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
    2017 400 citations Ali Afshar‐Oromieh, Tim Holland‐Letz et al. profile →
  11. Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention
    2019 370 citations Annette Altmann, Frederik L. Giesel et al. Journal of Nuclear Medicine profile →
  12. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
    2015 332 citations Ali Afshar‐Oromieh, Clemens Kratochwil et al. Journal of Nuclear Medicine profile →
  13. 213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
    2014 315 citations Clemens Kratochwil, Frederik L. Giesel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walter Mier Germany 61 6.6k 5.8k 4.7k 3.8k 2.3k 243 15.1k
Victor A. Levin United States 65 2.4k 0.4× 3.8k 0.7× 5.0k 1.1× 5.1k 1.3× 1.9k 0.8× 279 16.3k
Roger Schibli Switzerland 63 9.2k 1.4× 4.8k 0.8× 3.4k 0.7× 3.3k 0.9× 438 0.2× 375 14.8k
Matthias Eder Germany 57 5.9k 0.9× 3.3k 0.6× 6.1k 1.3× 3.0k 0.8× 1.4k 0.6× 199 13.2k
Nai‐Kong V. Cheung United States 69 2.3k 0.3× 5.5k 1.0× 1.7k 0.4× 6.8k 1.8× 3.0k 1.3× 392 16.7k
Kenji Tamura Japan 51 1.7k 0.3× 6.5k 1.1× 3.3k 0.7× 3.5k 0.9× 2.5k 1.1× 387 11.9k
Dihua Yu United States 73 2.8k 0.4× 9.0k 1.6× 2.9k 0.6× 10.9k 2.9× 3.9k 1.7× 242 19.0k
Dennis E. Hallahan United States 66 2.8k 0.4× 3.2k 0.5× 1.9k 0.4× 6.5k 1.7× 1.9k 0.8× 267 13.3k
Christel Herold‐Mende Germany 63 1.4k 0.2× 4.3k 0.7× 1.7k 0.4× 6.3k 1.7× 3.6k 1.6× 313 14.4k
Marion de Jong Netherlands 60 6.2k 0.9× 6.4k 1.1× 1.9k 0.4× 1.7k 0.5× 420 0.2× 246 13.5k
Warren D.W. Heston United States 55 3.6k 0.5× 2.6k 0.4× 5.3k 1.1× 3.9k 1.0× 1.0k 0.5× 151 10.8k

Countries citing papers authored by Walter Mier

Since Specialization
Citations

This map shows the geographic impact of Walter Mier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Mier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Mier more than expected).

Fields of papers citing papers by Walter Mier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Mier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Mier. The network helps show where Walter Mier may publish in the future.

Co-authorship network of co-authors of Walter Mier

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Mier. A scholar is included among the top collaborators of Walter Mier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Mier. Walter Mier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mier, Walter, et al.. (2023). Oral Delivery of mRNA by Liposomes Functionalized with Cell-Penetrating Peptides. SHILAP Revista de lepidopterología. 4(4). 293–308. 1 indexed citations
3.
Schäfer, Martin, Ulrike Bauder‐Wüst, Barbro Beijer, et al.. (2022). Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617. Frontiers in Chemistry. 10. 898692–898692. 2 indexed citations
4.
Fricker, Gert, et al.. (2021). Trends in Liposomal Nanocarrier Strategies for The Oral Delivery of Biologics. Nanomedicine. 16(20). 1813–1832. 7 indexed citations
5.
Chiblak, Sara, Zili Tang, Dieter Lemke, et al.. (2019). Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche. JCI Insight. 4(2). 60 indexed citations
6.
Rathke, Hendrik, Tim Holland‐Letz, Walter Mier, et al.. (2019). Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase. Journal of Nuclear Medicine. 61(5). 689–695. 48 indexed citations
7.
Uhl, Philipp, Max Sauter, Tammy C. T. Lan, et al.. (2018). Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor model. OncoImmunology. 8(1). e1524694–e1524694. 13 indexed citations
8.
Altmann, Annette, Max Sauter, Saskia Roesch, et al.. (2017). Identification of a Novel ITGαvβ6-Binding Peptide Using Protein Separation and Phage Display. Clinical Cancer Research. 23(15). 4170–4180. 45 indexed citations
9.
Heinbockel, Lena, Sebastian Marwitz, Raquel Ferrer‐Espada, et al.. (2015). Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis. PLoS ONE. 10(7). e0133291–e0133291. 12 indexed citations
10.
Kratochwil, Clemens, M. Stefanova, Eleni Mavriopoulou, et al.. (2014). SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors. Molecular Imaging and Biology. 17(3). 313–318. 165 indexed citations
11.
Rønnest, Mads H., et al.. (2013). A Mild Method for Regioselective Labeling of Aromatics with Radioactive Iodine. European Journal of Organic Chemistry. 2013(19). 3970–3973. 9 indexed citations
12.
Raab, Marc S., Iris Breitkreutz, Simon Anderhub, et al.. (2012). GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo. Cancer Research. 72(20). 5374–5385. 56 indexed citations
13.
Zoller, Frederic, Annette Markert, Philippe Barthe, et al.. (2012). Combination of Phage Display and Molecular Grafting Generates Highly Specific Tumor‐Targeting Miniproteins. Angewandte Chemie International Edition. 51(52). 13136–13139. 36 indexed citations
14.
Haberkorn, Uwe, Michael Eisenhut, Annette Altmann, & Walter Mier. (2009). Molecular endoradiotherapy of cancer. 21(1). 5–19. 1 indexed citations
15.
Zitzmann-Kolbe, Sabine, Susanne Krämer, Christel Herold‐Mende, et al.. (2009). Identification and Characterization of a Peptide with Affinity to Head and Neck Cancer. Journal of Nuclear Medicine. 50(3). 426–434. 37 indexed citations
16.
Boy, Regine García, et al.. (2007). Stabilisation of small proteins for their use as pharmacological scaffolds: why knot?. 25(3). 37–39. 1 indexed citations
17.
Chen, Libo, Annette Altmann, Walter Mier, et al.. (2006). Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.. PubMed. 47(5). 854–62. 42 indexed citations
18.
Schneider, Armin, Carola Krüger, Tobias Steigleder, et al.. (2005). The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. Journal of Clinical Investigation. 115(8). 2083–2098. 563 indexed citations breakdown →
19.
Brix, Gunnar, et al.. (2005). Biodistribution and pharmacokinetics of the 19F-labeled radiosensitizer 3-aminobenzamide: assessment by 19F MR imaging. Magnetic Resonance Imaging. 23(9). 967–976. 7 indexed citations
20.
Mier, Walter, et al.. (2004). Impaired absorption of marked oligopeptide Glycine-131I Tyrosine-Glycine after successful autologous-allotopic ileal mucosa transplantation in beagles. Journal of Pediatric Surgery. 39(10). 1553–1557. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor A. Levin Breakdown of academic impact, for papers by Roger Schibli Breakdown of academic impact, for papers by Matthias Eder Breakdown of academic impact, for papers by Nai‐Kong V. Cheung Breakdown of academic impact, for papers by Kenji Tamura Breakdown of academic impact, for papers by Dihua Yu Breakdown of academic impact, for papers by Dennis E. Hallahan Breakdown of academic impact, for papers by Christel Herold‐Mende Breakdown of academic impact, for papers by Marion de Jong Breakdown of academic impact, for papers by Warren D.W. Heston
Rankless by CCL
2026